Arcturus Therapeutics Holdings Inc. (ARCT)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 25.57 |
| Open | 25.56 |
| Bid | 27.85 x 100 |
| Ask | 27.98 x 100 |
| Day's range | 25.56 - 28.42 |
| 52-week range | 17.52 - 43.81 |
| Volume | |
| Avg. volume | 501,903 |
| Market cap | 751.56M |
| Beta (5Y monthly) | 2.60 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Analysts Estimate Arcturus Therapeutics (ARCT) to Report a Decline in Earnings: What to Look Out for
Arcturus Therapeutics (ARCT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Simply Wall St.
Arcturus Therapeutics Holdings' (NASDAQ:ARCT) investors will be pleased with their impressive 284% return over the last five years
It might be of some concern to shareholders to see the Arcturus Therapeutics Holdings Inc. ( NASDAQ:ARCT ) share price...
- GuruFocus.com
Arcturus Therapeutics Holdings Inc (ARCT) Insider Sells Shares
Arcturus Therapeutics Holdings Inc (NASDAQ:ARCT), a biotechnology company focused on the discovery, development, and commercialization of RNA therapeutics for rare diseases and vaccines, has reported an insider transaction.
© 2024 Yahoo. All rights reserved.